PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsMaxillary sinusitis
MeSH D015523 - maxillary sinusitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012852:Sinusitis
120 Companies
50 Drugs
$
Success rate
D015523: 
Maxillary sinusitis
40 Companies
2 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaLevofloxacin Levofloxacin  2011-06-20   
Glenmark PharmaceuticalsLevofloxacin Levofloxacin  2011-06-20   
NATCO PharmaLevofloxacin Levofloxacin  2011-06-20   
MylanLevofloxacin Levofloxacin  2011-06-20   
Johnson & JohnsonLevofloxacin Levaquin  1996-12-20   
Lupin ResearchLevofloxacin Levofloxacin  2011-06-20   
SandozLevofloxacin Levofloxacin  2011-06-20   
Chartwell PharmaceuticalsLevofloxacin Levofloxacin  2012-03-30   
Aurobindo PharmaLevofloxacin Levofloxacin  2011-06-20   
Dr Reddys LaboratoriesLevofloxacin Levofloxacin  2011-06-20   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
83%
5/6
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Johnson & Johnson
Levofloxacin,
Clavulanic acid,
Clavulin,
Clavamox
Dr Reddys Laboratories
Levofloxacin
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use